Newsletter Signup

Every Stocks to Buy Now newsletter highlights one primary and high-potential play we’ve been watching for a while, as well as several additional undervalued stocks we believe are worth a second glance. We’ll save you the step of mining the market for potential plays and deliver fresh opportunities right to your inbox.

You’re just a click and email verification away from joining hundreds of other subscribers receiving weekly trading ideas and the right stocks to buy now!

P.S. We will never spam you or sell your information.

 

 

 

From Our Blog

Building a New Cancer Care Ecosystem: Liora’s Proton Therapy and LIXTE’s Drug Pipeline in Synergy

March 9, 2026

Recently, LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company, acquired Liora Technologies, a company that is aiming to transform cancer care with innovative compact proton therapy. Specifically, Liora has created the LiGHT System, which is believed to provide many advantages over other proton therapy methods and systems that are currently available. While it […]

Rotate your device 90° to view site.